Bertin Bioreagent

anti-TIF1γ, mAb (3E9)

As low as CHF 778.00
In stock
Only %1 left
BRT-G01101-R100100 µlCHF 778.00
 

Specifications / Handling

More Information
Product Details
Synonyms Transcription Intermediary Factor 1-gamma; E3 Ubiquitin-protein Ligase Trim33; Tripartite Motif-containing Protein 33; RING-type E3 Ubiquitin Transferase TRIM33; RET-fused Gene 7 Protein; Protein Rfg7; EC:2.3.2.27
Product Type Monoclonal Antibody
Properties
Clone 3E9
Isotype Mouse IgG1κ
Source/Host Mouse
Immunogen/Antigen Synthetic peptide.
Application ELISA, Western Blot, Immunocytochemistry. Recommended dilutions: 1/500-1/5000.
Specificity Recognizes human and mouse TIF1 gamma. No cross reactivity on TIF1 alpha and TIF1 beta.
Formulation Liquid. Does not contain any preservative.
Other Product Data

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.

Declaration Manufactured by Bertin Bioreagent
Shipping and Handling
Shipping BLUE ICE
Long Term Storage -20°C
Handling Advice Avoid freeze/thaw cycles.
Use/Stability Stable for at least 3 years after receipt when stored at -20°C.
Documents
Product Specification Sheet
Datasheet Download PDF Download PDF

Scientific Background Information

Product Description
TIF1γ is a multifunctional protein involved in gene regulation, chromatin remodeling and cell signaling. It acts as a co-regulator of transcription factors, particularly in the TGF-β/SMAD signaling pathway. It promotes SMAD4 ubiquitination, preventing excessive TGF-β signaling, which is critical for controlling cell proliferation and differentiation. TIF1γ functions as a co-repressor or co-activator of transcription factors. It binds to chromatin and modifies histones, influencing gene expression. It plays a role in hematopoiesis (blood cell development) by regulating lineage-specific genes. TIF1γ acts as a tumor suppressor and helps regulate innate immunity by modulating inflammatory pathways. Altered TIF1γ function has been linked to cancers such as pancreatic, liver, and hematologic malignancies.
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.